Cargando…

2166. Preparedness for Candida auris in Canadian Nosocomial Infection Surveillance Program (CNISP) Hospitals, 2018

BACKGROUND: C. auris is a rapidly emerging pathogen which is potentially multidrug resistant, has caused large hospital outbreaks, and is difficult to identify in the routine microbiology laboratory. We surveyed CNISP sites to evaluate infection prevention and control (IPAC) and microbiology laborat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeldes, Felipe Garcia, McGeer, Allison, Bharat, Amrita, Mitchell, Robyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254434/ http://dx.doi.org/10.1093/ofid/ofy210.1822

Ejemplares similares

Prevalence of Candida auris in Canadian acute care hospitals among at-risk patients, 2018
por: Garcia-Jeldes, Hector Felipe, et al.
Publicado: (2020)

Laboratory-confirmed pandemic H1N1 influenca in hospitalized adults – findings from the Canadian Nosocomial Infection Surveillance Program (CNISP), 2009-10
por: Taylor, G, et al.
Publicado: (2011)

Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017
por: Belkin, Ana, et al.
Publicado: (2018)

Incursions of Candida auris into Australia, 2018
por: Lane, Courtney R., et al.
Publicado: (2020)

Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018
por: Rudnick, Wallis, et al.
Publicado: (2023)

Molecular Diagnostics in the Times of Surveillance for Candida auris
por: Kordalewska, Milena, et al.
Publicado: (2019)

Potential Fifth Clade of Candida auris, Iran, 2018
por: Chow, Nancy A., et al.
Publicado: (2019)

Candida auris: epidemiological situation, laboratory capacity and preparedness in the European Union and European Economic Area*, January 2018 to May 2019
por: Plachouras, Diamantis, et al.
Publicado: (2020)

Draft Genome Sequence of Lactobacillus rhamnosus 2166
por: Karlyshev, Andrey V., et al.
Publicado: (2014)

Posture App (version 2.1.66)
por: Healy, Heather S.
Publicado: (2020)

Undesired Effect of Vancomycin Prolonged Treatment: Enhanced Biofilm Production of the Nosocomial Pathogen Candida auris
por: Maione, Angela, et al.
Publicado: (2022)

Candida auris: a novel emerging nosocomial pathogen – properties, epidemiological situation and infection control
por: Caliman Sato, Marcelo, et al.
Publicado: (2023)

Laboratory‐based surveillance of Candida auris in Colombia, 2016–2020
por: Escandón, Patricia, et al.
Publicado: (2021)

Utility of CHROMagar™ Candida Plus for presumptive identification of Candida auris from surveillance samples
por: Marathe, Anuradha, et al.
Publicado: (2022)

Is Candida auris sexual?
por: Ross, Zoe K., et al.
Publicado: (2020)

Candida auris is Coming
por: Hegde, Ashit
Publicado: (2022)

Candida auris rates in blood culture on the rise: results of US surveillance
por: Noble, Brooklyn A., et al.
Publicado: (2023)

Screening for Candida auris in patients admitted to eight intensive care units in England, 2017 to 2018
por: Sharp, Ashley, et al.
Publicado: (2021)

NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris
por: Cleare, Levi G., et al.
Publicado: (2020)

Isolation of Candida auris from Ear of Otherwise Healthy Patient, Austria, 2018
por: Pekard-Amenitsch, Shiva, et al.
Publicado: (2018)

PB2166: TET ENZYMES PROTECT AGAINST FATAL LYMPHOPROLIFERATION
por: Spoeck, S., et al.
Publicado: (2022)

Candida auris in the Age of Resistance
por: Oh, Michael, et al.
Publicado: (2020)

Candida auris in Dog Ears
por: Yadav, Anamika, et al.
Publicado: (2023)

1720. Isolation and Characterization of Candida auris From an Active Surveillance System in Texas
por: Alam, M Jahangir, et al.
Publicado: (2019)

Antimicrobial use among adult inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program: 2009 to 2016
por: Rudnick, Wallis, et al.
Publicado: (2020)

Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022
por: Mitchell, Robyn, et al.
Publicado: (2023)

Immunopathogenesis of Emerging Candida auris and Candida haemulonii Strains
por: Pharkjaksu, Sujiraphong, et al.
Publicado: (2021)

In Vitro Activity of New Cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008–2011
por: Green, Karen, et al.
Publicado: (2014)

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017
por: Kohlenberg, Anke, et al.
Publicado: (2018)

Notes from the Field: Surveillance for Candida auris — Colombia, September 2016–May 2017
por: Escandón, Patricia, et al.
Publicado: (2018)

Community-Scale Wastewater Surveillance of Candida auris during an Ongoing Outbreak in Southern Nevada
por: Barber, Casey, et al.
Publicado: (2023)

2464. Implementation of a Candida auris admission surveillance protocol at the NIH Clinical Center
por: Forrester, LaToya A, et al.
Publicado: (2023)

Candida auris Candidemia in Kuwait, 2014
por: Emara, Maha, et al.
Publicado: (2015)

Identification of Drug Resistant Candida auris
por: Kordalewska, Milena, et al.
Publicado: (2019)

Candida auris: An emerging pathogen “incognito”?
por: Nett, Jeniel E.
Publicado: (2019)

Candida auris Bloodstream Infections in Russia
por: Barantsevich, Natalia E., et al.
Publicado: (2020)

Candida auris—“Ten Years After”
por: Meis, Jacques F., et al.
Publicado: (2019)

An Overview on Candida auris in Healthcare Settings
por: Cristina, Maria Luisa, et al.
Publicado: (2023)

Candida auris in skilled nursing facilities
por: Yune, Philip S., et al.
Publicado: (2023)

2474. Emergence of Candida auris in Michigan
por: McNamara, Sara E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ntkj4486tu7tkhpf70ei3dushh